An Efficacy and Safety Study of JNJ-42756493 in Participants with Urothelial Cancer

Mise à jour : Il y a 4 ans
Référence : EUCTR2014-002408-26

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

The primary objective of the study is: * To evaluate the objective response rate (complete response [CR]+ partial response [PR]) of the selected dose regimen in subjects with metastatic or surgically unresectable


Critère d'inclusion

  • Urothelial cancer